Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. [electronic resource]
Producer: 20140407Description: 648-55 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Biomarkers, Tumor -- genetics
- Cetuximab
- Clinical Trials, Phase III as Topic
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Epidermal Growth Factor -- biosynthesis
- Epiregulin
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Middle Aged
- Mutation
- Neoplasm Staging
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.